A study into the long-term health impacts of coronavirus, led by experts from the University of Leicester, Imperial College ...
Abnormally high levels of lung-injury biomarkers in the blood after COVID-19 infection may flag patients at risk for ongoing lung disease, an Imperial College London–led study suggests.
Blood-based biomarker testing might identify patients at increased risk for chronic lung disease following hospitalization for COVID-19.
The £1.1m Rosetta Stone study hopes to make a breakthrough by comparing both conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results